New Aquis admission: Samarkand

New Apex segment entry Samarkand helps companies sell their products in China, as well as selling its own brands in the market. The company has developed e-commerce software technology known as Nomad.

Samarkand moved into profit in the eight months to November 2020, helped by a protective equipment contract from the NHS. Even so, underlying revenues have been growing and the cash raised will help to increase the scale of the business.

Adding further brands to the company’s own portfolio could be highly lucrative. The experience of providing services to other companies has enabled Samarkand to develop expertise that can be used to market its own brands in China.

The share price has risen from the issue price of 115p to 123.5p (120p/127p). There was an impressive level of trading f...

This is Premium Member Content. Please register to become a UK Investor Magazine Member or login below.

Previous articleGameStop saga continues on day of volatile trading
Next articleLook out for XF-73 Destiny
Andrew Hore
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.